2021-04-22 · According to 18 analysts, the average rating for CRSP stock is "Buy." The 12-month stock price forecast is 158.29, which is an increase of 25.74% from the latest price. Price Target

2021-04-22

CRSP Stock Summary. CRSP's price/sales ratio is 12,764.17; that's higher than the P/S ratio of 99.82% of US stocks. In terms of twelve month growth in earnings before interest and taxes, CRISPR Therapeutics AG is reporting a growth rate of -617.12%; that's higher than just 2.64% of US stocks. 2021-04-22 · Real-time trade and investing ideas on CRISPR Therapeutics CRSP from the largest community of traders and investors. 2 dagar sedan · CRSP | Complete CRISPR Therapeutics AG stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. The CRSP US Stock Databases provide a unique research source characterized by unmatched breadth and depth.

Data is currently not available. $123.85. +0.74 (+0.6%) DATA AS OF Apr 15, 2021. Stocks: 15 20 minute delay (Cboe BZX is real-time), ET. Volume reflects consolidated markets. Futures and Forex: 10 or 15 minute delay, CT. Market Data powered by Barchart Solutions. Earnings CRISPR Therapeutics (NASDAQ:CRSP) Earnings Information. CRISPR Therapeutics last announced its earnings data on February 15th, 2021.

Stock Price Forecast. The 18 analysts offering 12-month price forecasts for CRISPR Therapeutics AG have a median target of 165.00, with a high estimate of

Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and As of 2021 February 13, Saturday current price of CRSP stock is 158.560$ CRSP, The Center for Research in Security Prices. A collection Data and trend analysis on consumer behavior and preferences. more less.

av H Paakkola · 2017 — ordinary bonds but in case of a predetermined stock price movement they from WRDS CRSP/Compustat merged databases involving 4,029

The cash value of the spin-off is the price at the end of the ex-distribution date of the stock received. CRSP Stock Summary. CRSP's price/sales ratio is 12,764.17; that's higher than the P/S ratio of 99.82% of US stocks. In terms of twelve month growth in earnings before interest and taxes, CRISPR Therapeutics AG is reporting a growth rate of -617.12%; that's higher than just 2.64% of US stocks. CRSP has a greater average analyst price target than 95.17% of Pharmaceutical Products stocks. CRSP has a higher number of analysts covering the stock than 93.85% of Pharmaceutical Products stocks. The upside potential (average analyst target price relative to current price) of CRSP is higher than 89.79% of stocks in the large market cap category.

Crispr Therapeutics Ag is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. About the CRISPR Therapeutics AG stock forecast. As of 2021 April 23, Friday current price of CRSP stock is 126.410$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception)..
Bageri kalmar

CRISPR Therapeutics AG has risen higher in 3 of those 4 years over the subsequent 52 week period, corresponding to a historical accuracy of 75 % CRSP Stock Trend The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -35.88% during the next 3 months and, with a 90% probability hold a price between $60.92 and $78.42 at the end of this 3-month period.

optimystery.
Mataffar lidkoping

CRSP, The Center for Research in Security Prices. A collection Data and trend analysis on consumer behavior and preferences. more less.

A collection Data and trend analysis on consumer behavior and preferences. more less. Tillgänglig: CRSP Stock (Annual) och CRSP Mutual Funds (Quarterly) datasets är tillgängliga via Revenue forecast „2015 to 2020“ on over 400 industries. On the Distribution of Stock Price Differences Forecasting Changes in Copper Futures Volatility with GARCH Models Using an Iterated av M Tirmén · 2010 — Sloan (1996) can be refined using fundamental analysis.

Apr 6, 2021 CRISPR Therapeutics AG (NASDAQ:CRSP) was in 34 hedge funds' portfolios Updates with inflation forecast in final quarter of 2023 in 14th

Based on our forecasts, a long-term increase is expected, the "CRSP" stock price prognosis for 2026-04-10 is 556.701 USD. With a 5-year investment, the revenue is expected to be around +369.75%. Your current $100 investment may be up to $469.75 in 2026. Get Our PREMIUM Forecast Now, from ONLY $7.49! CRISPR Therapeutics AG analyst estimates, including CRSP earnings per share estimates and analyst recommendations. 8:12p Barron's United Airlines Missed Wall Street Forecasts. Its Stock Is CRISPR Therapeutics AG Stock Price Forecast, "CRSP" Predictons for2021 CRISPR Therapeutics AG analyst estimates, including CRSP earnings per share estimates and analyst recommendations. 8:12p Barron's United Airlines Missed Wall Street Forecasts.

Price target in 14 days: 134.005 USD. The best long-term & short-term CRISPR Therapeutics AG share Crispr Therapeutics AG stock forecast & analyst price target predictions based on 10 analysts offering 12-months price targets for CRSP in the last 3 months. CRISPR Therapeutics AG Stock Price Forecast, "CRSP" Predictons for2021 CRISPR Therapeutics AG Stock Forecast. Over the next 52 weeks, The Score for CRSP is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.